Novartis says may divest generic drugs unit Sandoz - NewsBreak
By Suzana in Business
Updated 3 years ago
Oct 26 (Reuters) - Novartis (NOVN.S) on Tuesday raised the prospect of divesting its generic drugs unit Sandoz and lifted its peak revenue estimate for its two best-selling pharmaceuticals. "Novartis has commenced a strategic review of the Sandoz Division. The review will explore all options, ranging from retaining the business...
